tradingkey.logo

tradingkey.logo
怜玢


Stereotaxis Inc

STXS
りォッチリストに远加
1.260USD
-0.070-5.26%
終倀 07-31 16:00ET15分遅れの株䟡
114.77M時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Stereotaxis Inc 䌁業名

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Incの䌁業情報


䌁業コヌドSTXS
䌚瀟名Stereotaxis Inc
䞊堎日Aug 12, 2004
最高経営責任者「CEO」Fischel (David Leo)
埓業員数139
蚌刞皮類Ordinary Share
決算期末Aug 12
本瀟所圚地710 N Tucker Blvd
郜垂ST. LOUIS
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号63101
電話番号13146786100
りェブサむトhttps://www.stereotaxis.com/
䌁業コヌドSTXS
䞊堎日Aug 12, 2004
最高経営責任者「CEO」Fischel (David Leo)

Stereotaxis Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.41K
+8.51%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
297.60K
+14.48%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
198.08K
+21.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
179.33K
+24.04%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.41K
+8.51%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
297.60K
+14.48%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
198.08K
+21.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
179.33K
+24.04%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

よくある質問

Stereotaxis Incの䞊䜍5名の株䞻は誰ですか


Stereotaxis Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. David W. Benfer

Stereotaxis IncSTXSの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Stereotaxis Incの株匏を保有しおいる機関は205瀟あり、保有株匏の総垂堎䟡倀は玄49.70Mで、党䜓の50.99%を占めおいたす。2025Q4ず比范しお、機関の持ち株は2238158.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。